Richard D. Klausner's most recent trade in Lyell Immunopharma Inc was a trade of 158,000 Common Stock done at an average price of $0.6 . Disclosure was reported to the exchange on March 14, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Lyell Immunopharma Inc | Richard D. Klausner | Director | Purchase of securities on an exchange or from another person at price $ 0.60 per share. | 14 Mar 2025 | 158,000 | 843,365 | - | 0.6 | 94,942 | Common Stock |
Lyell Immunopharma Inc | Richard D. Klausner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 130,000 | 130,000 | - | - | Option (right to buy) | |
Lyell Immunopharma Inc | Richard D. Klausner | Director | Sale of securities on an exchange or to another person at price $ 2.28 per share. | 15 Aug 2023 | 58,020 | 930,880 | - | 2.3 | 132,286 | Common Stock |
Lyell Immunopharma Inc | Richard D. Klausner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 65,000 | 65,000 | - | - | Option (right to buy) | |
Lyell Immunopharma Inc | Richard D. Klausner | Director | Sale of securities on an exchange or to another person at price $ 6.40 per share. | 23 Sep 2022 | 11,100 | 988,900 | - | 6.4 | 71,041 | Common Stock |